Risk factors for Haemophilus influenzae and pneumococcal respiratory tract colonization in CVID

J Allergy Clin Immunol. 2018 Dec;142(6):1999-2002.e3. doi: 10.1016/j.jaci.2018.08.014. Epub 2018 Aug 28.

Affiliations

¹ Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
² Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
³ Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Electronic address: isabella.quinti@uniroma1.it.

PMID: 30170126
DOI: 10.1016/j.jaci.2018.08.014

No abstract available

Publication types

Letter
Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Common Variable Immunodeficiency* / immunology
Common Variable Immunodeficiency* / microbiology
Female
Haemophilus Infections* / immunology
Haemophilus Infections* / microbiology
Haemophilus influenzae* / drug effects
Haemophilus influenzae* / genetics
Haemophilus influenzae* / growth & development
Haemophilus influenzae* / isolation & purification
Humans
Immunoglobulin A / blood
Immunoglobulin G / therapeutic use
Immunoglobulin M / blood
Male
Middle Aged
Nasopharynx / microbiology
Oropharynx / microbiology
Pneumococcal Infections* / immunology
Pneumococcal Infections* / microbiology
Respiratory Tract Infections* / immunology
Respiratory Tract Infections* / microbiology
Risk Factors
Streptococcus pneumoniae* / drug effects
Streptococcus pneumoniae* / genetics
Streptococcus pneumoniae* / growth & development
Streptococcus pneumoniae* / isolation & purification
Young Adult

Substances

Anti-Bacterial Agents
Immunoglobulin A
Immunoglobulin G
Immunoglobulin M